- Headquarters
- Boston, Massachusetts
- Business Model
- B2B
- Total Funding
- $48.0M
- Last Round
- $30.0M Extension RoundDec 2025
- Rounds
- 2
About
Developing a pro-cytokine fusion protein platform for oncology indications.
Summary
Proviva Therapeutics is a Biotech company based in Boston, United States. It has raised $48.0M in total across 2 rounds, most recently a $30.0M Extension Round round in Dec 2025. Investors include OrbiMed, Longpan Investment and Hankang Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform